Highbridge Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Highbridge Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-616,860	Closed	-$2.5M	–	362
2023 Q4	$2.5M	Buy	+616,860	New	+$1.88M	0.1%	88

Highbridge Capital Management's THRX Position: Q1 2024 in Review

Highbridge Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 616,860 shares — an estimated $2.5M sold.

Highbridge Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $2.5M in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Highbridge Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Highbridge Capital Management sold 616,860 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $2.5M.
Highbridge Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Highbridge Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $2.5M in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Highbridge Capital Management's 13F filing for Q1 2024, filed 10 May 2024.